TrialsgrambetaRCTs are beautiful

PARTNER 2A

2016

Placement of Aortic Transcatheter Valves 2, Cohort A

In 2,032 intermediate-risk patients with severe aortic stenosis, transcatheter aortic-valve replacement was non-inferior for 2-year death or disabling stroke compared with surgical aortic-valve replacement.

Result

Efficacy: Death from any cause or disabling stroke at 2 yearsHR 0.89 (95% CI 0.73-1.09) · P = 0.001

Below 1 favours transcatheter aortic-valve replacement, above 1 favours surgical aortic-valve replacement.

Event rates
Absolute difference
1.8 points

The absolute difference is derived from the event rates.

Also reported: With a trend favouring TAVR in the transfemoral cohort.

Original publication
Subtopic
TAVR
Design
Multicentre RCT, non-inferiority
Relevance
Supporting: context rather than must-know.
Source
Leon MB, et al. N Engl J Med. 2016;374(17):1609-20.doi 10.1056/NEJMoa1514616

Discussion & critique

Used the now-superseded SAPIEN XT (more paravalvular leak and vascular complications) and included transthoracic access in some patients. Pivotal in extending TAVR from high-risk to intermediate-risk aortic stenosis.

Discussed in podcasts